Abstract Background: Hospital admissions for patients living with opioid use disorder (OUD) are increasing, and patient-centred interventions are required to maximize the impact of OUD treatment. It is important to continue pharmacotherapy for hospitalized patients with OUD to prevent withdrawal and self-directed discharge. Objectives: The primary objective was to identify the proportion of any OUD pharmacotherapy administered more than 24 hours after hospital presentation.